ADUS Addus HomeCare Corporation
$121.24▲ +0.06%
Healthcare
Other
After hours
$121.24▲ +0.00%
Oct 27, 4:00 PM ET
Volume 216.6K
Avg Volume (10D) 171.2K
Key Metrics & Fundamentals
Market Cap
$2.26B
P/E Ratio
21.2
Div Yield
0.00%
52W Range
87.95 - 124.44
% vs 50 MA
3.86%
% vs 200 MA
14.21%
RSI-14
64.6
MACD Histogram
+0.8400
Beta (1Y vs SPY)
0.17
Free Cash Flow
$38.67M
Gross Rev
$377.42M
Gross Profit
$121.56M
EBITDA
$43.63M
COGS
$255.86M
Operating Exp
$82.62M
Operating Income
$38.94M
EBIT
$38.94M
Pretax Income
$37.78M
Net Income
$27.61M
EPS (Diluted)
1.48
Price & Volume History
Loading chart…
Recent News

Quest Diagnostics (DGX) Q3 Earnings and Revenues Beat Estimates
Zacks · Oct 22, 2026 7:00 AM ET

What Are Hims & Hers Health Stock Bears Missing?
Trefis · Oct 19, 2026 4:24 PM ET

Addus HomeCare Announces Third Quarter 2026 Earnings Release and Conference Call
Business Wire · Oct 13, 2026 11:00 AM ET

Should You Trim Or Add To Your Hims & Hers Position Now?
Trefis · Oct 12, 2026 6:53 PM ET

Is Hims & Hers Stock Ready For A Longer Cash Burn?
Trefis · Oct 8, 2026 5:39 PM ET

BTSG Deploys AI Across Operations: Will It Improve Margins?
Zacks · Sep 30, 2026 9:19 AM ET

At-Home Healthcare Is Growing Fast: Can CAH Ride the Trend?
Zacks · Sep 28, 2026 1:31 PM ET

2 Safe-and-Steady Stocks with Exciting Potential and 1 That Underwhelm
StockStory · Sep 28, 2026 7:50 AM ET

Can Addus HomeCare (ADUS) Compound Wealth at Scale?
Insider Monkey · Sep 23, 2026 7:08 AM ET

Addus HomeCare (ADUS) Heads To Jefferies, Is It Still 13% Undervalued?
Simply Wall St. · Sep 16, 2026 1:12 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ADUS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.